APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flutamide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Flutamide Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchFlutamide Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Flutamide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Flutamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flutamide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Flutamide Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Flutamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Flutamide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Flutamide market include Tasly Diyi Pharma, Forward, SANDOZ, Merck, TEVA Pharma, Florencia Healthcare, Cipla LifeScience and Actiza Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flutamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flutamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flutamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flutamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Flutamide Segment by Company

Tasly Diyi Pharma

Forward

SANDOZ

Merck

TEVA Pharma

Florencia Healthcare

Cipla LifeScience

Actiza Pharma

Flutamide Segment by Type

Flutamide Tablets

Flutamide Capsule

Others

Flutamide Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Flutamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Flutamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Flutamide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Flutamide significant trends, drivers, influence factors in global and regions.

6. To analyze Flutamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flutamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flutamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flutamide industry.

Chapter 3: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Flutamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Flutamide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Flutamide Industry Trends Table 2. Flutamide Industry Drivers Table 3. Flutamide Industry Opportunities and Challenges Table 4. Flutamide Industry Restraints Table 5. Global Flutamide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Flutamide Revenue Share by Company (2021-2026) Table 7. Global Flutamide Sales Volume by Company (kg) & (2021-2026) Table 8. Global Flutamide Sales Volume Share by Company (2021-2026) Table 9. Global Flutamide Average Price (US$/kg) of Company (2021-2026) Table 10. Global Flutamide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Flutamide Key Company Manufacturing Base & Headquarters Table 12. Global Flutamide Company, Product Type & Application Table 13. Global Flutamide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Flutamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Flutamide Tablets Table 18. Significant Companies of Flutamide Capsule Table 19. Significant Companies of Others Table 20. Global Flutamide Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Flutamide Sales Volume by Type (2021-2026) & (kg) Table 22. Global Flutamide Sales Volume by Type (2027-2032) & (kg) Table 23. Global Flutamide Sales Volume Share by Type (2021-2026) Table 24. Global Flutamide Sales Volume Share by Type (2027-2032) Table 25. Global Flutamide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Flutamide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Flutamide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Flutamide Sales Value Share by Type (2021-2026) Table 29. Global Flutamide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Retail Pharmacies Table 33. Global Flutamide Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 34. Global Flutamide Sales Volume by Application (2021-2026) & (kg) Table 35. Global Flutamide Sales Volume by Application (2027-2032) & (kg) Table 36. Global Flutamide Sales Volume Share by Application (2021-2026) Table 37. Global Flutamide Sales Volume Share by Application (2027-2032) Table 38. Global Flutamide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Flutamide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Flutamide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Flutamide Sales Value Share by Application (2021-2026) Table 42. Global Flutamide Sales Value Share by Application (2027-2032) Table 43. Global Flutamide Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 44. Global Flutamide Sales by Region (2021-2026) & (kg) Table 45. Global Flutamide Sales Market Share by Region (2021-2026) Table 46. Global Flutamide Sales by Region (2027-2032) & (kg) Table 47. Global Flutamide Sales Market Share by Region (2027-2032) Table 48. Global Flutamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Flutamide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Flutamide Sales Value Share by Region (2021-2026) Table 51. Global Flutamide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Flutamide Sales Value Share by Region (2027-2032) Table 53. Global Flutamide Market Average Price (US$/kg) by Region (2021-2026) Table 54. Global Flutamide Market Average Price (US$/kg) by Region (2027-2032) Table 55. Global Flutamide Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 56. Global Flutamide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Flutamide Sales by Country (2021-2026) & (kg) Table 58. Global Flutamide Sales Market Share by Country (2021-2026) Table 59. Global Flutamide Sales by Country (2027-2032) & (kg) Table 60. Global Flutamide Sales Market Share by Country (2027-2032) Table 61. Global Flutamide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Flutamide Sales Value Market Share by Country (2021-2026) Table 63. Global Flutamide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Flutamide Sales Value Market Share by Country (2027-2032) Table 65. Tasly Diyi Pharma Company Information Table 66. Tasly Diyi Pharma Business Overview Table 67. Tasly Diyi Pharma Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 68. Tasly Diyi Pharma Flutamide Product Portfolio Table 69. Tasly Diyi Pharma Recent Development Table 70. Forward Company Information Table 71. Forward Business Overview Table 72. Forward Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 73. Forward Flutamide Product Portfolio Table 74. Forward Recent Development Table 75. SANDOZ Company Information Table 76. SANDOZ Business Overview Table 77. SANDOZ Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 78. SANDOZ Flutamide Product Portfolio Table 79. SANDOZ Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 83. Merck Flutamide Product Portfolio Table 84. Merck Recent Development Table 85. TEVA Pharma Company Information Table 86. TEVA Pharma Business Overview Table 87. TEVA Pharma Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 88. TEVA Pharma Flutamide Product Portfolio Table 89. TEVA Pharma Recent Development Table 90. Florencia Healthcare Company Information Table 91. Florencia Healthcare Business Overview Table 92. Florencia Healthcare Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 93. Florencia Healthcare Flutamide Product Portfolio Table 94. Florencia Healthcare Recent Development Table 95. Cipla LifeScience Company Information Table 96. Cipla LifeScience Business Overview Table 97. Cipla LifeScience Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 98. Cipla LifeScience Flutamide Product Portfolio Table 99. Cipla LifeScience Recent Development Table 100. Actiza Pharma Company Information Table 101. Actiza Pharma Business Overview Table 102. Actiza Pharma Flutamide Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 103. Actiza Pharma Flutamide Product Portfolio Table 104. Actiza Pharma Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Flutamide Distributors List Table 108. Flutamide Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Flutamide Product Image Figure 2. Global Flutamide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flutamide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Flutamide Sales (2021-2032) & (kg) Figure 5. Global Flutamide Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Flutamide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Flutamide Tablets Image Figure 10. Flutamide Capsule Image Figure 11. Others Image Figure 12. Global Flutamide Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Flutamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Flutamide Sales Volume Share by Type (2021-2032) Figure 15. Global Flutamide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Flutamide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Flutamide Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Global Flutamide Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 22. Global Flutamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Flutamide Sales Volume Share by Application (2021-2032) Figure 24. Global Flutamide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Flutamide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Flutamide Sales Value Share by Application (2021-2032) Figure 27. Global Flutamide Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 28. Global Flutamide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Flutamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Flutamide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Flutamide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Flutamide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Flutamide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Flutamide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Flutamide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Flutamide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Flutamide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Flutamide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Flutamide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Flutamide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Flutamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Flutamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Flutamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Flutamide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Flutamide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Flutamide Tablets
  • Flutamide Capsule
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Tasly Diyi Pharma
  • Forward
  • SANDOZ
  • Merck
  • TEVA Pharma
  • Florencia Healthcare
  • Cipla LifeScience
  • Actiza Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flutamide Sales Value (2021-2032)
  4. 1.2.2 Global Flutamide Sales Volume (2021-2032)
  5. 1.2.3 Global Flutamide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Flutamide Market Dynamics
  1. 2.1 Flutamide Industry Trends
  2. 2.2 Flutamide Industry Drivers
  3. 2.3 Flutamide Industry Opportunities and Challenges
  4. 2.4 Flutamide Industry Restraints
3 Flutamide Market by Company
  1. 3.1 Global Flutamide Company Revenue Ranking in 2025
  2. 3.2 Global Flutamide Revenue by Company (2021-2026)
  3. 3.3 Global Flutamide Sales Volume by Company (2021-2026)
  4. 3.4 Global Flutamide Average Price by Company (2021-2026)
  5. 3.5 Global Flutamide Company Ranking (2024-2026)
  6. 3.6 Global Flutamide Company Manufacturing Base and Headquarters
  7. 3.7 Global Flutamide Company Product Type and Application
  8. 3.8 Global Flutamide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Flutamide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Flutamide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Flutamide Market by Type
  1. 4.1 Flutamide Type Introduction
  2. 4.1.1 Flutamide Tablets
  3. 4.1.2 Flutamide Capsule
  4. 4.1.3 Others
  5. 4.2 Global Flutamide Sales Volume by Type
  6. 4.2.1 Global Flutamide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Flutamide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Flutamide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Flutamide Sales Value by Type
  10. 4.3.1 Global Flutamide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Flutamide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Flutamide Sales Value Share by Type (2021-2032)
5 Flutamide Market by Application
  1. 5.1 Flutamide Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Flutamide Sales Volume by Application
  6. 5.2.1 Global Flutamide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flutamide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Flutamide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Flutamide Sales Value by Application
  10. 5.3.1 Global Flutamide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Flutamide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Flutamide Sales Value Share by Application (2021-2032)
6 Flutamide Regional Sales and Value Analysis
  1. 6.1 Global Flutamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flutamide Sales by Region (2021-2032)
  3. 6.2.1 Global Flutamide Sales by Region: 2021-2026
  4. 6.2.2 Global Flutamide Sales by Region (2027-2032)
  5. 6.3 Global Flutamide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Flutamide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Flutamide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Flutamide Sales Value by Region (2027-2032)
  9. 6.5 Global Flutamide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Flutamide Sales Value (2021-2032)
  12. 6.6.2 North America Flutamide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Flutamide Sales Value (2021-2032)
  15. 6.7.2 Europe Flutamide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Flutamide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Flutamide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Flutamide Sales Value (2021-2032)
  21. 6.9.2 South America Flutamide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Flutamide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Flutamide Sales Value Share by Country, 2025 VS 2032
7 Flutamide Country-level Sales and Value Analysis
  1. 7.1 Global Flutamide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Flutamide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Flutamide Sales by Country (2021-2032)
  4. 7.3.1 Global Flutamide Sales by Country (2021-2026)
  5. 7.3.2 Global Flutamide Sales by Country (2027-2032)
  6. 7.4 Global Flutamide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Flutamide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Flutamide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Flutamide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Flutamide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Flutamide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Flutamide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Flutamide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Flutamide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Flutamide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Flutamide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Flutamide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Flutamide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Flutamide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Flutamide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Flutamide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Flutamide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Flutamide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Flutamide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Flutamide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Flutamide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Flutamide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Flutamide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Flutamide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Flutamide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Flutamide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Flutamide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Flutamide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Flutamide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Flutamide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Flutamide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Flutamide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Flutamide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Flutamide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Flutamide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Flutamide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Flutamide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Flutamide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Flutamide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Flutamide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Flutamide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Flutamide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Flutamide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Flutamide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Flutamide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Flutamide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Flutamide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Flutamide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Flutamide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Flutamide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Flutamide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Flutamide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Flutamide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Flutamide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Flutamide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Flutamide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Flutamide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Flutamide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Flutamide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Flutamide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Flutamide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Flutamide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Flutamide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Flutamide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Flutamide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Flutamide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Flutamide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Flutamide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Flutamide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Flutamide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Flutamide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Flutamide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Flutamide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Flutamide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Flutamide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Flutamide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Flutamide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Flutamide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Flutamide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Flutamide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Flutamide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Flutamide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Flutamide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Flutamide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Flutamide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Flutamide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Flutamide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tasly Diyi Pharma
  2. 8.1.1 Tasly Diyi Pharma Company Information
  3. 8.1.2 Tasly Diyi Pharma Business Overview
  4. 8.1.3 Tasly Diyi Pharma Flutamide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tasly Diyi Pharma Flutamide Product Portfolio
  6. 8.1.5 Tasly Diyi Pharma Recent Developments
  7. 8.2 Forward
  8. 8.2.1 Forward Company Information
  9. 8.2.2 Forward Business Overview
  10. 8.2.3 Forward Flutamide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Forward Flutamide Product Portfolio
  12. 8.2.5 Forward Recent Developments
  13. 8.3 SANDOZ
  14. 8.3.1 SANDOZ Company Information
  15. 8.3.2 SANDOZ Business Overview
  16. 8.3.3 SANDOZ Flutamide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SANDOZ Flutamide Product Portfolio
  18. 8.3.5 SANDOZ Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Flutamide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Flutamide Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 TEVA Pharma
  26. 8.5.1 TEVA Pharma Company Information
  27. 8.5.2 TEVA Pharma Business Overview
  28. 8.5.3 TEVA Pharma Flutamide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TEVA Pharma Flutamide Product Portfolio
  30. 8.5.5 TEVA Pharma Recent Developments
  31. 8.6 Florencia Healthcare
  32. 8.6.1 Florencia Healthcare Company Information
  33. 8.6.2 Florencia Healthcare Business Overview
  34. 8.6.3 Florencia Healthcare Flutamide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Florencia Healthcare Flutamide Product Portfolio
  36. 8.6.5 Florencia Healthcare Recent Developments
  37. 8.7 Cipla LifeScience
  38. 8.7.1 Cipla LifeScience Company Information
  39. 8.7.2 Cipla LifeScience Business Overview
  40. 8.7.3 Cipla LifeScience Flutamide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cipla LifeScience Flutamide Product Portfolio
  42. 8.7.5 Cipla LifeScience Recent Developments
  43. 8.8 Actiza Pharma
  44. 8.8.1 Actiza Pharma Company Information
  45. 8.8.2 Actiza Pharma Business Overview
  46. 8.8.3 Actiza Pharma Flutamide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Actiza Pharma Flutamide Product Portfolio
  48. 8.8.5 Actiza Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flutamide Value Chain Analysis
  2. 9.1.1 Flutamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flutamide Sales Mode & Process
  6. 9.2 Flutamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flutamide Distributors
  9. 9.2.3 Flutamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst